Clinical Trial Update: Efficacy Pilot Study of Triflusal in the Attenuation of Insulin Resistance in Human Obesity [Phase 2]

View source ↗

Summary

Phase 2 efficacy pilot trial evaluating whether triflusal can attenuate insulin resistance in obesity has completed. The study was sponsored by J. Uriach and Co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity

Drugs mentioned

• Triflusal (triflusal)

Snippet

Sponsor: J. Uriach and Company | Conditions: Insulin Resistance | Phase 2 | Status: COMPLETED